Pinnacle Associates’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-10,737
Closed -$861K 678
2016
Q4
$861K Sell
10,737
-14
-0.1% -$1.11K 0.02% 408
2016
Q3
$857K Sell
10,751
-123
-1% -$9.93K 0.02% 396
2016
Q2
$848K Sell
10,874
-632
-5% -$45.1K 0.02% 393
2016
Q1
$633K Sell
11,506
-222
-2% -$12.1K 0.01% 425
2015
Q4
$724K Buy
11,728
+2,452
+26% +$155K 0.02% 411
2015
Q3
$585K Buy
9,276
+1,902
+26% +$136K 0.01% 443
2015
Q2
$539K Buy
7,374
+27
+0.4% +$1.95K 0.01% 462
2015
Q1
$481K Buy
7,347
+151
+2% +$10K 0.01% 467
2014
Q4
$468K Buy
7,196
+1
+0% +$64 0.01% 465
2014
Q3
$433K Buy
7,195
+2
+0% +$131 0.01% 481
2014
Q2
$498K Sell
7,193
-224
-3% -$14.5K 0.01% 463
2014
Q1
$485K Buy
7,417
+1
+0% +$65 0.01% 460
2013
Q4
$459K Sell
7,416
-148
-2% -$8.57K 0.01% 469
2013
Q3
$406K Buy
7,564
+1
+0% +$52 0.01% 467
2013
Q2
$345K Buy
+7,563
New +$328K 0.01% 463

Other funds holding STJ

Pinnacle Associates's STJ Position: Q1 2017 in Review

Pinnacle Associates sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 10,737 shares — an estimated $861K sold.

Pinnacle Associates first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $861K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Pinnacle Associates reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Pinnacle Associates sold 10,737 St Jude Medical shares in Q1 2017, an estimated $861K.
  • Pinnacle Associates first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Pinnacle Associates's St Jude Medical position peaked at $861K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Pinnacle Associates's 13F filing for Q1 2017, filed 10 May 2017.